Kelvin A. Moses, MD, PhD, FACS, presented “Multi-Disciplinary Approach to Advanced Prostate Cancer Care” during the 7th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2023.
This content is available free to the GRU Community. Login or create an account to view it.
How to cite: Moses, Kelvin A. “Multi-Disciplinary Approach to Advanced Prostate Cancer Care.” September 22, 2023. Accessed Aug 2024. https://grandroundsinurology.com/multi-disciplinary-approach-to-advanced-prostate-cancer-care/
Multi-Disciplinary Approach to Advanced Prostate Cancer Care – Summary
Kelvin A. Moses, MD, PhD, FACS, explores a multidisciplinary approach to advanced prostate cancer care, emphasizing the importance of integrating diverse medical specialties to enhance patient outcomes in this treatment. He highlights the need for a comprehensive treatment strategy that incorporates the expertise of urologists, oncologists, radiologists, pathologists, and genetic counselors.
Dr. Moses discusses how multi-parametric MRI, next-generation sequencing, and liquid biopsies contribute to more accurate staging and risk stratification, enabling the identification of actionable genetic mutations and molecular targets, and allowing for precise and individualized therapeutic interventions. He highlights successful collaborations between different medical specialties that have led to significant advancements in treatment protocols. By fostering a collaborative environment, healthcare teams can ensure that all aspects of a patient’s care are addressed, from diagnosis through treatment and follow-up.
The Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a unique multi-disciplinary forum organized to inform the key health care stakeholders about the emerging advances in clinical case and research and create a consensus-based vision for the future of precision care and educational and research strategy for its realization. The mission of the Summit is to fill the currently existing gap between the key experts of in vivo imaging, the world authorities in the in vitro fluid- and tissue-based molecular diagnostics, including genomics, and thought leaders in the development of novel observation strategies (e.g., active surveillance, or AS) and therapeutic interventions.
ABOUT THE AUTHOR
Dr. Kelvin A. Moses is Associate Professor of Urology at Vanderbilt University Medical Center, and director of the Comprehensive Prostate Cancer clinic. He is a Phi Beta Kappa graduate of Morehouse College, and received his MD and PhD training at Baylor College of Medicine in Houston, TX. He completed his General Surgery internship and Urology training at Emory University, followed by a fellowship in Urologic Oncology at Memorial Sloan-Kettering Cancer Center, where he served as Chief Administrative Fellow. His clinical practice focuses on advanced prostate cancer, including several clinical trials, as well as surgical management of advanced renal, penile, and testicular cancer. Dr. Moses’s research is focused on addressing health disparities in urologic cancers, determining the role of health literacy in patient interactions with the health care system, and optimal care for patients with metastatic and/or castrate-resistant prostate cancer.
